Latest news

Thumbnail image for European Commission expands use for Janssen’s Erleada

European Commission expands use for Janssen’s Erleada

The extension is based on data from the Phase III TITAN study, which assessed the addition of the drug to androgen deprivation therapy in a broad range of patients with metastatic hormone-sensitive prostate cancer.

29th January 2020

Previous  --   2 3 4 5 6 7 8 9 10 11   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download